Greenstone Alprazolam XR Recall: Dissolution Failure
Greenstone LLC recalls specific lots of 3 mg alprazolam XR tablets due to failed dissolution specifications. Check your bottle's lot number and expiration date.
Use caution until it’s fixed
Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
Contact the company
What happened, in plain English
Viatris Inc., through distributor Greenstone LLC, is recalling a specific batch of alprazolam XR extended-release tablets (3 mg) because they failed dissolution specifications. This means the medication may not release or work as intended. The recall affects 6,789 bottles distributed nationwide in the USA. Read more at govinfonow.com/recall/34806-greenstone-alprazolam-xr-recall-dissolution-failure.
Source Summary by GovInfoNow · govinfonow.com/recall/34806-greenstone-alprazolam-xr-recall-dissolution-failure · Updated October 10, 2026 · FDA enforcement record: FDA #D-0844-2022
Cite this page
“Greenstone Alprazolam XR Recall: Dissolution Failure.” GovInfoNow, updated October 10, 2026. https://govinfonow.com/recall/34806-greenstone-alprazolam-xr-recall-dissolution-failure. Based on FDA recall #D-0844-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0844-2022%22&limit=1).
Why it’s dangerous
The tablets failed dissolution specifications, meaning they may not release the drug properly in the body. This could result in the medication not working effectively to treat the condition it was prescribed for.
Who’s affected
Patients currently taking alprazolam XR extended-release tablets for anxiety or panic disorders who purchased the recalled product. Individuals with this specific prescription are at risk of receiving medication that does not perform as expected.
How to tell if you have this one
Check your bottle for NDC 59762-0068-1 and Lot # EH8348 with an expiration date of August 2023. The product is a 3 mg, 60-count bottle of alprazolam XR extended-release tablets distributed by Greenstone LLC.
- Brand
Greenstone- Category
Drug
What to do — step by step
Check Your Bottle
Verify if your alprazolam XR bottle matches NDC 59762-0068-1, Lot # EH8348, and expires in August 2023.
Contact Your Pharmacist
If you have the recalled product, contact your pharmacist or healthcare provider for instructions on replacement or disposal.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0844-2022 (April 28, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0844-2022 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.